» Articles » PMID: 34776851

Quality of Life and a Surveillant Endocannabinoid System

Abstract

The endocannabinoid system (ECS) is an important brain modulatory network. ECS regulates brain homeostasis throughout development, from progenitor fate decision to neuro- and gliogenesis, synaptogenesis, brain plasticity and circuit repair, up to learning, memory, fear, protection, and death. It is a major player in the hypothalamic-peripheral system-adipose tissue in the regulation of food intake, energy storage, nutritional status, and adipose tissue mass, consequently affecting obesity. Loss of ECS control might affect mood disorders (anxiety, hyperactivity, psychosis, and depression), lead to drug abuse, and impact neurodegenerative (Alzheimer's, Parkinson, Huntington, Multiple, and Amyotrophic Lateral Sclerosis) and neurodevelopmental (autism spectrum) disorders. Practice of regular physical and/or mind-body mindfulness and meditative activities have been shown to modulate endocannabinoid (eCB) levels, in addition to other players as brain-derived neurotrophic factor (BDNF). ECS is involved in pain, inflammation, metabolic and cardiovascular dysfunctions, general immune responses (asthma, allergy, and arthritis) and tumor expansion, both/either in the brain and/or in the periphery. The reason for such a vast impact is the fact that arachidonic acid, a precursor of eCBs, is present in every membrane cell of the body and on demand eCBs synthesis is regulated by electrical activity and calcium shifts. Novel lipid (lipoxins and resolvins) or peptide (hemopressin) players of the ECS also operate as regulators of physiological allostasis. Indeed, the presence of cannabinoid receptors in intracellular organelles as mitochondria or lysosomes, or in nuclear targets as PPARγ might impact energy consumption, metabolism and cell death. To live a better life implies in a vigilant ECS, through healthy diet selection (based on a balanced omega-3 and -6 polyunsaturated fatty acids), weekly exercises and meditation therapy, all of which regulating eCBs levels, surrounded by a constructive social network. Cannabidiol, a diet supplement has been a major player with anti-inflammatory, anxiolytic, antidepressant, and antioxidant activities. Cognitive challenges and emotional intelligence might strengthen the ECS, which is built on a variety of synapses that modify human behavior. As therapeutically concerned, the ECS is essential for maintaining homeostasis and cannabinoids are promising tools to control innumerous targets.

Citing Articles

Physical Exercise Improves the Neuronal Function in Ischemic Stroke Via Microglial CBR/P2Y12 Signaling.

He X, Yang X, Li G, Zhao Y, Luo J, Xu J Mol Neurobiol. 2024; 62(2):2039-2057.

PMID: 39066973 DOI: 10.1007/s12035-024-04391-2.


Fish oil supplementation during pregnancy decreases liver endocannabinoid system and lipogenic markers in newborn rats exposed to maternal high-fat diet.

Fassarella L, Neto J, Woyames J, Santos G, Pereira H, Pazos-Moura C Eur J Nutr. 2024; 63(5):1565-1579.

PMID: 38727803 DOI: 10.1007/s00394-024-03422-x.


Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment.

Stanciu G, Ababei D, Solcan C, Uritu C, Craciun V, Pricope C Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675490 PMC: 11053678. DOI: 10.3390/ph17040530.


The effect of and its postbiotics on the expression of genes involved in the endocannabinoid system and intestinal epithelial integrity in Caco-2 cells.

Malek A, Ahmadi Badi S, Karimi G, Bizouarn T, Irian S, Siadat S J Diabetes Metab Disord. 2023; 22(2):1417-1424.

PMID: 37975078 PMC: 10638345. DOI: 10.1007/s40200-023-01264-8.


Long-Term Treatment with Cannabidiol-Enriched Extract Induces Synaptic Changes in the Adolescent Rat Hippocampus.

Aguiar A, Campos R, Isaac A, Paes-Colli Y, Carvalho V, Sampaio L Int J Mol Sci. 2023; 24(14).

PMID: 37511537 PMC: 10380262. DOI: 10.3390/ijms241411775.


References
1.
de Oliveira E, Quitete F, Bernardino D, Guarda D, Caramez F, Soares P . Maternal coconut oil intake on lactation programs for endocannabinoid system dysfunction in adult offspring. Food Chem Toxicol. 2019; 130:12-21. DOI: 10.1016/j.fct.2019.05.002. View

2.
Mazzola C, Micale V, Drago F . Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol. 2003; 477(3):219-25. DOI: 10.1016/j.ejphar.2003.08.026. View

3.
McKenna M, Schuck P, Ferreira G . Fundamentals of CNS energy metabolism and alterations in lysosomal storage diseases. J Neurochem. 2018; 148(5):590-599. DOI: 10.1111/jnc.14577. View

4.
Micale V, Di Marzo V, Sulcova A, Wotjak C, Drago F . Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther. 2012; 138(1):18-37. DOI: 10.1016/j.pharmthera.2012.12.002. View

5.
Cunha J, Carlini E, Pereira A, Ramos O, Pimentel C, Gagliardi R . Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology. 1980; 21(3):175-85. DOI: 10.1159/000137430. View